The Human Cathelicidin LL-37 Has Antiviral Activity against Respiratory Syncytial Virus
Open Access
- 30 August 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (8), e73659
- https://doi.org/10.1371/journal.pone.0073659
Abstract
Respiratory syncytial virus is a leading cause of lower respiratory tract illness among infants, the elderly and immunocompromised individuals. Currently, there is no effective vaccine or disease modifying treatment available and novel interventions are urgently required. Cathelicidins are cationic host defence peptides expressed in the inflamed lung, with key roles in innate host defence against infection. We demonstrate that the human cathelicidin LL-37 has effective antiviral activity against RSV in vitro, retained by a truncated central peptide fragment. LL-37 prevented virus-induced cell death in epithelial cultures, significantly inhibited the production of new infectious particles and diminished the spread of infection, with antiviral effects directed both against the viral particles and the epithelial cells. LL-37 may represent an important targetable component of innate host defence against RSV infection. Prophylactic modulation of LL-37 expression and/or use of synthetic analogues post-infection may represent future novel strategies against RSV infection.Keywords
This publication has 47 references indexed in Scilit:
- Cationic Host Defence Peptides: Potential as Antiviral TherapeuticsBioDrugs, 2013
- Early infection with respiratory syncytial virus impairs regulatory T cell function and increases susceptibility to allergic asthmaNature Medicine, 2012
- Hydrolyzable Tannins (Chebulagic Acid and Punicalagin) Target Viral Glycoprotein-Glycosaminoglycan Interactions To Inhibit Herpes Simplex Virus 1 Entry and Cell-to-Cell SpreadJournal of Virology, 2011
- Viral Load Drives Disease in Humans Experimentally Infected with Respiratory Syncytial VirusAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysisThe Lancet, 2010
- Respiratory Viral Infections in Infants: Causes, Clinical Symptoms, Virology, and ImmunologyClinical Microbiology Reviews, 2010
- Phenylbutyrate Induces Antimicrobial Peptide ExpressionAntimicrobial Agents and Chemotherapy, 2009
- AMPed up immunity: how antimicrobial peptides have multiple roles in immune defenseTrends in Immunology, 2009
- Role of Human β-Defensin-2 during Tumor Necrosis Factor-α/NF-κB-mediated Innate Antiviral Response against Human Respiratory Syncytial VirusOnline Journal of Public Health Informatics, 2008
- Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin D3Journal of Cystic Fibrosis, 2007